Accelerated Immunodeficiency-associated Vaccine-derived Poliovirus Serotype 3 Sequence Evolution Rate in an 11-week-old Boy With X-linked Agammaglobulinemia and Perinatal Human Immunodeficiency Virus Exposure.


Journal

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
ISSN: 1537-6591
Titre abrégé: Clin Infect Dis
Pays: United States
ID NLM: 9203213

Informations de publication

Date de publication:
01 01 2020
Historique:
received: 04 02 2019
accepted: 29 04 2019
pubmed: 16 5 2019
medline: 7 1 2021
entrez: 16 5 2019
Statut: ppublish

Résumé

Primary B-cell immunodeficiencies are risk factors for the generation of vaccine-derived polioviruses. We report immunodeficiency-associated vaccine-derived poliovirus serotype 3 in an 11-week-old boy with X-linked agammaglobulinemia. Unique characteristics of this case include early age of presentation, high viral evolutionary rate, and the child's perinatal exposure to human immunodeficiency virus.

Identifiants

pubmed: 31086993
pii: 5489041
doi: 10.1093/cid/ciz361
pmc: PMC6912151
doi:

Substances chimiques

Poliovirus Vaccine, Oral 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

132-135

Subventions

Organisme : World Health Organization
ID : 001
Pays : International

Informations de copyright

© The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America.

Références

Acta Paediatr. 2012 Nov;101(11):e500-4
pubmed: 22816388
J Virol. 2008 May;82(9):4429-40
pubmed: 18287242
Int J Immunogenet. 2006 Jun;33(3):205-9
pubmed: 16712653
Hum Mol Genet. 1995 Jan;4(1):51-8
pubmed: 7711734
Acta Paediatr. 1993 Dec;82(12):1034-8
pubmed: 8155920
Wkly Epidemiol Rec. 2016 Mar 25;91(12):145-68
pubmed: 27039410
Arch Pediatr Adolesc Med. 1994 May;148(5):479-85
pubmed: 8180638
Virus Res. 2008 Oct;137(1):168-72
pubmed: 18674576
Nature. 1985 Apr 11-17;314(6011):548-50
pubmed: 2986004
Front Immunol. 2017 Sep 25;8:1103
pubmed: 28993765
Front Immunol. 2016 Sep 28;7:383
pubmed: 27733852
Vaccine. 2018 Mar 20;36(13):1711-1719
pubmed: 29478755
Emerg Infect Dis. 2012 Jun;18(6):992-4
pubmed: 22607733

Auteurs

Sabelle Jallow (S)

Centre for Vaccines and Immunology, National Institute for Communicable Diseases, National Health Laboratory Service, Johannesburg.

Jo M Wilmshurst (JM)

Department of Paediatric Neurology, Neuroscience Institute, Red Cross War Memorial Children's Hospital, University of Cape Town, South Africa.

Wayne Howard (W)

Centre for Vaccines and Immunology, National Institute for Communicable Diseases, National Health Laboratory Service, Johannesburg.

Julie Copelyn (J)

Paediatric Infectious Diseases Unit, Red Cross War Memorial Children's Hospital, University of Cape Town, South Africa.
Department of Paediatrics and Child Health, University of Cape Town, South Africa.

Lerato Seakamela (L)

Centre for Vaccines and Immunology, National Institute for Communicable Diseases, National Health Laboratory Service, Johannesburg.

Koon-Wing Chan (KW)

Department of Paediatrics and Adolescent Medicine, University of Hong Kong, China.

Robert Sebunya (R)

Department of Paediatric Neurology, Neuroscience Institute, Red Cross War Memorial Children's Hospital, University of Cape Town, South Africa.

Rosinah Sibiya (R)

Centre for Vaccines and Immunology, National Institute for Communicable Diseases, National Health Laboratory Service, Johannesburg.

Heleen Du Plessis (H)

Centre for Vaccines and Immunology, National Institute for Communicable Diseases, National Health Laboratory Service, Johannesburg.

Charlene Jacobs (C)

Division of Public Health, Surveillance and Response, Department of Health, Provincial Government of the Western Cape, Cape Town.

Natacha Berkowitz (N)

Department of City Health, Social Services Directorate, Cape Town.

Lucille Blumberg (L)

Public Health Surveillance and Response Division, Johannesburg.

Kerrigan McCarthy (K)

Outbreak Response Unit, National Institute for Communicable Diseases, National Health Laboratory Service, Johannesburg.

Elizabeth Maseti (E)

Child, Youth and School Health, National Department of Health, Pretoria, South Africa.

Mercy Kamupira (M)

World Health Organization (WHO) Country Office, Pretoria, South Africa.

Nonhlanhla Dlamini (N)

Child, Youth and School Health, National Department of Health, Pretoria, South Africa.

Nicksy Gumede (N)

WHO Regional Office for Africa, Brazzaville, Republic of Congo.

Ousmane M Diop (OM)

Polio Department, WHO Strategic Initiatives Cluster, Geneva, Switzerland.

Yu Lung Lau (YL)

Department of Paediatrics and Adolescent Medicine, University of Hong Kong, China.

Shelina Moonsamy (S)

Centre for Vaccines and Immunology, National Institute for Communicable Diseases, National Health Laboratory Service, Johannesburg.

Brian Eley (B)

Paediatric Infectious Diseases Unit, Red Cross War Memorial Children's Hospital, University of Cape Town, South Africa.
Department of Paediatrics and Child Health, University of Cape Town, South Africa.

Melinda Suchard (M)

Centre for Vaccines and Immunology, National Institute for Communicable Diseases, National Health Laboratory Service, Johannesburg.
Chemical Pathology, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH